Rockefeller Capital Management L.P. Care Dx, Inc. Transaction History

Rockefeller Capital Management L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$10.88 - $20.05 $1,338 - $2,466	-123 Reduced 2.99%	3,985 $45,000
Q3 2022 Nov 02, 2022	BUY	$16.06 - $26.39 $48,260 - $79,301	3,005 Added 272.44%	4,108 $69,000
Q2 2022 Aug 12, 2022	BUY	$20.49 - $39.72 $3,934 - $7,626	192 Added 21.08%	1,103 $23,000
Q1 2022 May 13, 2022	SELL	$28.19 - $46.6 $28 - $46	-1 Reduced 0.11%	911 $33,000
Q4 2021 Feb 14, 2022	BUY	$41.2 - $73.6 $453 - $809	11 Added 1.22%	912 $41,000
Q3 2021 Nov 12, 2021	SELL	$59.15 - $91.99 $51,223 - $79,663	-866 Reduced 49.01%	901 $57,000
Q2 2021 Aug 10, 2021	BUY	$63.02 - $95.11 $945 - $1,426	15 Added 0.86%	1,767 $161,000
Q1 2021 May 11, 2021	BUY	$57.62 - $95.6 $37,049 - $61,470	643 Added 57.98%	1,752 $119,000
Q4 2020 Feb 12, 2021	BUY	$41.43 - $77.09 $1,698 - $3,160	41 Added 3.84%	1,109 $80,000
Q3 2020 Nov 13, 2020	BUY	$30.88 - $37.94 $1,204 - $1,479	39 Added 3.79%	1,068 $40,000
Q2 2020 Aug 12, 2020	BUY	$18.95 - $35.43 $19,499 - $36,457	1,029 New	1,029 $36,000

219

53.2M

53.5K

23.9K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $942M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.